Abstract: The present invention relates to the cosmetic, nutraceutical and/or pharmaceutical, notably dermatological, use of a strain of Lactobacillus crispatus and/or of a composition comprising it for maintaining and/or increasing the expression of extracellular matrix molecules of the skin and/or of mucous membranes and notably for maintaining and/or increasing the biomechanical properties of healthy skin and/or healthy mucous membranes, preferentially the firmness and/or elasticity and/or density of healthy skin and/or healthy mucous membranes.

Abstract: Disclosed are embodiments of a multicellular spheroid, including a core containing first skin cells; the core can have an average diameter of about 10 ?m to about 900 ?m. The multicellular spheroid may further include a shell overlaying the core, the shell having second skin cells. Further disclosed are systems containing such multicellular spheroids and methods of preparation and use of multicellular spheroids.

Abstract: The present invention relates to the cosmetic use of a Khaya senegalensis extract, obtained by aqueous extraction, for maintaining and/or increasing the expression of collagen XVIII in the skin and/or the mucosae and/or the scalp and/or the skin appendages, for maintaining and/or increasing the firmness and/or the elasticity of the skin and/or the mucosae and/or the scalp and/or for reducing the visibility of the skin's pores and/or making the skin smoother and/or for limiting and/or reducing perspiration and/or limiting and/or reducing loss of head hair and/or body hair and/or increasing the growth of head hair and/or body hair and/or reducing or limiting sebum production.

Abstract: Methods of stabilizing color in a composition, which methods comprise: (a) providing an amino-substituted hydroxybenzophenone compound corresponding to the general formula (I): and (b) combining the amino-substituted hydroxybenzophenone compound with a composition to be stabilized selected from the group consisting of cosmetic preparations and dermatological preparations, are described along with compositions containing an organic dye and an amino-substituted hydroxybenzophenone compound corresponding to the general formula (I).

Abstract: The invention relates to novel hydrated lamellar phases or liposomes which contain either polyethylenimine, or a substance which stimulates intracellular penetration selected from the group consisting of: i) a fatty monoamine of carbon-containing chain length of between C10 and C18; ii) a cationic polymer, optionally at least one fluorescent compound which is essentially inert with respect to the intracellular penetration, which enables this penetration to be visualised. These liposomes are very useful in cosmetics or in pharmacy for stimulating the intracellular penetration of a substance or active principle.

Abstract: The present invention relates to UV filter capsules, to the use thereof for the preparation of cosmetic or dermatological formulations or dispersions, and to cosmetic or dermatological formulations which comprise the capsules, and to a process for the production thereof.

Abstract: Methods of stabilizing color in a composition, which methods comprise: (a) providing an amino-substituted hydroxybenzophenone compound corresponding to the general formula (I): and (b) combining the amino-substituted hydroxybenzophenone compound with a composition to be stabilized selected from the group consisting of cosmetic preparations and dermatological preparations, are described along with compositions containing an organic dye and an amino-substituted hydroxybenzophenone compound corresponding to the general formula (I).

Abstract: The present invention relates to the cosmetic use by the topical route of a Tapirira guianensis extract, for stimulating the expression of perlecan and/or dystroglycan and/or VE-cadherin and/or claudin-5, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction. It also relates to a cosmetic care method comprising the application, to at least one concerned area of healthy skin and/or healthy mucous membrane and/or healthy scalp, of a Tapirire guianensis extract or of a cosmetic composition comprising such an extract for stimulating the expression of perlecan and/or dystroglycan and/or VE-cadherin and/or claudin-5, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction. In addition, it relates to a cosmetic composition comprising a Tapirira guianensis extract and a topically acceptable cosmetic excipient.

Abstract: The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.

Abstract: The invention relates to the use of a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of the LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of the NRAGE of SEQ ID NO: 2 for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible to treat skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.

Abstract: The present invention relates to the topical cosmetic use of a Polygonum bistorta extract for stimulating the expression of perlecan and/or dystroglycan, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction. It also relates to a cosmetic care method comprising the application, to at least one concerned area of healthy skin and/or healthy mucous membrane and/or healthy scalp, of a Polygonum bistorta extract or of a cosmetic composition comprising such an extract for stimulating the expression of perlecan and of dystroglycan, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction.

Abstract: The present invention relates to a cosmetic method for increasing collagen gene and/or protein expression comprising topically applying an effective amount of an extract of the plant Quassia amara onto skin and/or mucous membranes. The present invention relates as well to a cosmetic method comprising topically applying an effective amount of such an extract for increasing the firmness of skin and/or mucous membranes of an individual in need thereof. The present invention also relates to a method of cosmetic care comprising topically applying a composition comprising an effective amount of the extract of Q. amara onto skin and/or mucous membranes, for increasing the collagen gene and/or protein expression.

Abstract: The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Abstract: The present invention relates to a process for the preparation of nanoparticulate zinc oxide in the form of aqueous suspensions or in the form of pulverulent solid. Furthermore, the invention relates to the use of zinc oxide particles and suspensions prepared in this way in cosmetic sunscreen preparations, as stabilizer in plastics, in paints, in coatings and as antimicrobial active ingredient.

Abstract: The invention relates to a novel active ingredient that stimulates the proliferation and/or the activity of fibroblasts and also to its applications in the cosmetic or pharmaceutical, in particular dermatological, field. In particular, the active ingredient according to the invention comprises a combination of at least one Hibiscus Abelmoschus extract and a soy extract containing at least peptides.

Abstract: The present invention concerns a novel agent which is capable of stimulating the expression of LOXL and of increasing quality and functionality of collagen fibres and has anti-oxidizing, anti-elastase, anti-MMP properties as well as its use in producing cosmetic or pharmaceutical compositions, especially dermatological compositions, or food compositions.

Abstract: The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Abstract: The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.

Abstract: The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of LOX of sequence ID no. 1, and/or that modulates the expression and/or activity of NRAGE of sequence ID no. 2, for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins in order to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered.

Abstract: The present invention relates to a process for the preparation of nanoparticulate zinc oxide in the form of aqueous suspensions or in the form of pulverulent solid. Furthermore, the invention relates to the use of zinc oxide particles and suspensions prepared in this way in cosmetic sunscreen preparations, as stabilizer in plastics, in paints, in coatings and as antimicrobial active ingredient.